BANK VONTOBEL/CALL/NOVO NORDISK ADR B/145/0.1/19.07.24 | Real-time Bid/Ask 08:24:59 2024-06-27 EDT | ||
| 0.36 EUR / 0.37 EUR | -17.05% |
|
| Current month | +140.44% | ||
| 1 month | +62.96% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
NOVO NORDISK A/S
Latest news about NOVO NORDISK A/S
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 0.38 | -13.64% |
| 24-06-26 | 0.44 | +33.33% |
| 24-06-25 | 0.33 | 0.00% |
| 24-06-24 | 0.33 | +10.00% |
| 24-06-21 | 0.3 | -9.09% |
Delayed Quote Börse Stuttgart
Last update June 27, 2024 at 02:44 am
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | NOVO NORDISK A/S |
| Issuer | 
Vontobel
|
| WKN | VD5VPA |
| ISIN | DE000VD5VPA2 |
| Date issued | 2024-05-08 |
| Strike | 145 $ |
| Maturity | 2024-07-19 (22 Days) |
| Parity | 10 : 1 |
| Emission price | 0.14 € |
| Emission volume | N/A |
| Settlement | Por diferencias |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.48 € |
|---|---|
| Lowest since issue | 0.128 € |
| Delta | 0.48x |
| Omega | 18.26 |
| Premium | 3.57x |
| Gearing | 37.83x |
| Moneyness | 0.9908 |
| Difference Strike | 1.33 $ |
| Difference Strike % | +0.92% |
| Spread | 0.01 € |
| Spread % | 2.78% |
| Theoretical value | 0.3650 |
| Implied Volatility | 30.63 % |
| Total Loss Probability | 54.61 % |
| Intrinsic value | 0.000000 |
| Present value | 0.3650 |
| Break even | 148.91 € |
| Theta | -0.08x |
| Vega | 0.01x |
| Rho | 0x |
Company Profile
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- diabetes and obesity treatment products (92.6%);
- rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc.
Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
Consensus: Novo Nordisk A/S
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
1,007
DKK
Average target price
937.9
DKK
Spread / Average Target
-6.86%
- Stock Market
- Warrants
- Warrant
